Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. CME
  3. Obesity

Timing of benefits of intentional weight loss in cardiometabolic disease

Timing of benefits of intentional weight loss in cardiometabolic disease
Restart
Resume
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Comments
  • Overview

    Large scale intentional weight loss in patients with cardiometabolic disease results in changes that are rapid, intermediate or that take longer. Naveed Sattar shares important learnings on this topic to understand and contextualize future trials.

  • Educational information

    This video was recorded in response to a recent publication in Cardiovascular Research by Sattar and colleagues.

  • Faculty

    Naveed Sattar is Professor of Metabolic Medicine, University of Glasgow, UK.

  • Disclosures

    This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

    Find this article online at Cardiovasc Res

    The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Recommended
Details
Presenters
Comments
  • Overview

    Large scale intentional weight loss in patients with cardiometabolic disease results in changes that are rapid, intermediate or that take longer. Naveed Sattar shares important learnings on this topic to understand and contextualize future trials.

  • Educational information

    This video was recorded in response to a recent publication in Cardiovascular Research by Sattar and colleagues.

  • Faculty

    Naveed Sattar is Professor of Metabolic Medicine, University of Glasgow, UK.

  • Disclosures

    This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

    Find this article online at Cardiovasc Res

    The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Schedule2 Dec 2024